Free Trial

This company recently went public with an IPO on Wednesday, March 26th 2025. They issued 2,100,000 shares at $25.00 per share. We will continue to update data for NTHI as it becomes available.

NASDAQ:NTHI

Neonc Technologies (NTHI) Stock Price, News & Analysis

Neonc Technologies logo
$9.58 +2.58 (+36.86%)
As of 04/3/2025 04:00 PM Eastern

About Neonc Technologies Stock (NASDAQ:NTHI)

Key Stats

Today's Range
$6.10
$10.44
50-Day Range
N/A
52-Week Range
$6.10
$25.00
Volume
110,051 shs
Average Volume
58,780 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Remove Ads
Receive NTHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neonc Technologies and its competitors with MarketBeat's FREE daily newsletter.

NTHI Stock News Headlines

Neonc Technologies appoints new accounting firm
NeOnc Technologies receives RPDD for NEO100
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
NeOnc Technologies Holdings Inc
NeOnc Falls Despite FDA Nod
See More Headlines

NTHI Stock Analysis - Frequently Asked Questions

Neonc Technologies' stock was trading at $12.00 at the start of the year. Since then, NTHI stock has decreased by 20.2% and is now trading at $9.58.
View the best growth stocks for 2025 here
.

Neonc Technologies (NTHI) raised $52 million in an IPO on Wednesday, March 26th 2025. The company issued 2,100,000 shares at a price of $25.00 per share. RBW Capital Partners (Division of Dawson James) acted as the underwriter for the IPO.

Shares of NTHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NTHI
Previous Symbol
NASDAQ:NTHI
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$83,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:NTHI) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners